Doctors’ AI scribes get names of drugs and diagnoses wrong, NHS watchdog warns

AI transcription tools used in England’s National Health Service are misrecording drug names and diagnoses in clinical notes, a mistake that could expose patients to inappropriate treatment and create liability for clinicians. The errors undermine the reliability of electronic health records that doctors depend on for prescribing and referral decisions. With patient safety and legal accountability at stake, the issue touches every general practice that has adopted automated note‑taking. BBC reporting cites a study that found AI‑driven note‑taking could omit vital clinical information, while The Guardian and Startup Fortune relay the NHS watchdog’s formal warning about the misrecordings.

Medical Xpress and Healthcare Dive add expert commentary that the inaccuracies elevate malpractice risk. Heise online notes that patients are sometimes spotting errors before clinicians review the records, highlighting a gap in verification. General practitioners, their patients, and the NHS as a commissioning body are directly impacted. Vendors supplying the AI scribe technology face scrutiny as hospitals weigh the trade‑off between efficiency gains and the risk of hidden documentation errors.

NHS trusts may commission independent audits of existing note‑taking systems and could suspend deployment pending remediation. Professional bodies are likely to issue updated guidance on verification procedures before AI‑generated records are accepted as definitive. Stakeholders will watch for any policy briefs or legislative proposals that address the balance between digital efficiency and clinical safety.